Cytosar-u and Adriamycin pfs drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cytosar-u (cytarabine) and Adriamycin pfs (doxorubicin hydrochloride). Common drug interactions include bladder fibrosis among females and alanine aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Cytosar-u and Adriamycin pfs. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Cytosar-u?

Cytosar-u has active ingredients of cytarabine. eHealthMe is studying from 586 Cytosar-u users. Check the latest studies of Cytosar-u.

What is Adriamycin pfs?

Adriamycin pfs has active ingredients of doxorubicin hydrochloride. eHealthMe is studying from 6,495 Adriamycin pfs users. Check the latest studies of Adriamycin pfs.

On Jul, 14, 2026

13 people who take Cytosar-u and Adriamycin pfs together, and have interactions are studied.

Cytosar-u and Adriamycin pfs drug interactions.

What are the common drug interactions of Cytosar-U and Adriamycin Pfs, by gender? *:

female:

Bladder fibrosis (formation of excess fibrous connective tissue in bladder)
Cerebellar ataxia (loss of coordination)
Haematuria (presence of blood in urine)
Urinary bladder haemorrhage (urinary bladder bleeding)
Ulcer
Asthenia (weakness)
Diarrhoea
Dizziness
Electrocardiogram t wave inversion
Haematocrit decreased

male:

Alanine aminotransferase increased
Anaemia (lack of blood)
Headache (pain in head)
Hodgkin's disease (cancer originating from white blood cells)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Lymphadenopathy (disease or enlargement of lymph nodes)
Nausea (feeling of having an urge to vomit)
Night sweats (sweating in night)
Oral disorder (mouth disease)
Oropharyngeal pain

What are the common drug interactions of Cytosar-U and Adriamycin Pfs, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Second primary malignancy (after getting cure a cancer, a new cancer development)

10-19:

Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)

20-29:

Alanine aminotransferase increased
Anaemia (lack of blood)
Anxiety
Aspartate aminotransferase increased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Dizziness
Eosinophilia (eosinophil count in the peripheral blood exceeds)
Fall
Fatigue (feeling of tiredness)
Febrile neutropenia (fever with reduced white blood cells)

30-39:

n/a

40-49:

Cardiomyopathy (weakening of the heart muscle)
Ejection fraction (the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat)
Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)

50-59:

Bladder fibrosis (formation of excess fibrous connective tissue in bladder)
Cerebellar ataxia (loss of coordination)
Haemoglobin decreased
Hypotension (abnormally low blood pressure)
Inflammation
Leukocytosis (increased white blood cells)
Mucosal ulceration (ulcers of mucous membrane)
Nausea (feeling of having an urge to vomit)
Sweating increased (excess sweating)
Vomiting

60+:

n/a

What are the existing conditions these people have? *

Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 3 people, 23.08%
Stress And Anxiety: 2 people, 15.38%
Nausea And Vomiting: 2 people, 15.38%
Nausea (feeling of having an urge to vomit): 2 people, 15.38%
Gastric Ph Decreased: 2 people, 15.38%
Gastric Disorder (disease of stomach): 2 people, 15.38%
Lymphocytic Leukaemia (a type of cancer in which the bone marrow makes too many lymphocytes): 1 person, 7.69%
Fungal Infection: 1 person, 7.69%
Breast Cancer Female: 1 person, 7.69%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Cytosar-u and Adriamycin pfs?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously